Skip to content
10-Q

Quarterly Report

MERIDIAN BIOSCIENCE, INC.

0001193125-23-029272

← back to feed
Filed
Feb 9, 2023 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Jan 30, 2023 44.04M sh
Shares Diluted Q1 2023 · Dec 31, 2022 43.9M sh
Shares Diluted Q1 2023 · Dec 31, 2021 44.03M sh
Capex Q1 2023 · Dec 31, 2022 $2.65M
Capex Q1 2023 · Dec 31, 2021 $1.71M
Operating Cash Flow Q1 2023 · Dec 31, 2022 −$2.35M
Operating Cash Flow Q1 2023 · Dec 31, 2021 $35.56M
Long Term Debt Q1 2023 · Dec 31, 2022 $25M
Long Term Debt Q1 2023 · Sep 30, 2022 $25M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $74.1M
Cash And Equivalents Q1 2023 · Sep 30, 2022 $81.45M
Stockholders Equity Q1 2023 · Dec 31, 2022 $340.54M
Stockholders Equity Q1 2023 · Sep 30, 2022 $368.06M
Stockholders Equity Q1 2023 · Dec 31, 2021 $345.22M
Stockholders Equity Q1 2023 · Sep 30, 2021 $328.3M
Current Liabilities Q1 2023 · Dec 31, 2022 $78.58M
Current Liabilities Q1 2023 · Sep 30, 2022 $57.95M
Current Assets Q1 2023 · Dec 31, 2022 $201.53M
Current Assets Q1 2023 · Sep 30, 2022 $210.6M
Total Assets Q1 2023 · Dec 31, 2022 $456.76M
Total Assets Q1 2023 · Sep 30, 2022 $463.1M
Eps Diluted Q1 2023 · Dec 31, 2022 −$0.68
Eps Diluted Q1 2023 · Dec 31, 2021 $0.35
Eps Basic Q1 2023 · Dec 31, 2022 −$0.68
Eps Basic Q1 2023 · Dec 31, 2021 $0.35
Sga Expense Q1 2023 · Dec 31, 2022 $11.07M
Sga Expense Q1 2023 · Dec 31, 2021 $14.66M
Rd Expense Q1 2023 · Dec 31, 2022 $6.18M
Rd Expense Q1 2023 · Dec 31, 2021 $6.19M
Net Income Q1 2023 · Dec 31, 2022 −$29.82M
Net Income Q1 2023 · Dec 31, 2021 $15.34M
Operating Income Q1 2023 · Dec 31, 2022 −$28.12M
Operating Income Q1 2023 · Dec 31, 2021 $20.28M
Gross Profit Q1 2023 · Dec 31, 2022 $31.51M
Gross Profit Q1 2023 · Dec 31, 2021 $49.16M
Cost Of Revenue Q1 2023 · Dec 31, 2022 $25.4M
Cost Of Revenue Q1 2023 · Dec 31, 2021 $39.18M
Revenue Q1 2023 · Dec 31, 2022 $56.9M
Revenue Q1 2023 · Dec 31, 2021 $88.34M